Showing results (581-590 of 941) with videos related to
Sort By:
Pageof 95
Diabetes & Vascular Disease Research|May 13, 2011
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse modelTracey Gaspari, HongBin Liu, Iresha Welungoda, et al.Diabetes & Vascular Disease Research|May 13, 2011
Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitusPriscilla L Hollander, Jia Li, Robert Frederich, et al.Diabetes & Vascular Disease Research|November 4, 2011
Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureasKaterina K Naka, Katerina Papathanassiou, Aris Bechlioulis, et al.Diabetes & Vascular Disease Research|October 14, 2011
Early adverse effect of abnormal glucose metabolism on arterial stiffness in drug naive hypertensive patientsGregory Vyssoulis, Panagiota Pietri, Charalambos Vlachopoulos, et al.Diabetes & Vascular Disease Research|November 9, 2011
Coronary artery disease is detectable by multi-slice computed tomography in most asymptomatic type 2 diabetic patients at high cardiovascular riskRodolfo Nasti, Ornella Carbonara, Maria L Mangoni di Santo Stefano, et al.Diabetes & Vascular Disease Research|November 9, 2011
Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patientsSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.Diabetes & Vascular Disease Research|January 12, 2012
Activin A and cardiovascular disease in type 2 diabetes mellitusThor Ueland, Pål Aukrust, Svend Aakhus, et al.Diabetes & Vascular Disease Research|January 12, 2012
Waist circumference is a strong and independent determinant of the distribution of HDL subfractions in overweight patients with cardiovascular risk factorsDavid Rosenbaum, Boris Hansel, Dominique Bonnefont-Rousselot, et al.Diabetes & Vascular Disease Research|April 18, 2012
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluationEberhard Standl, Oliver SchnellDiabetes & Vascular Disease Research|March 13, 2012
Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetesStephen J Nicholls, Kiyoko UnoPageof 95